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Pre-travel malaria enquiries to the United Kingdom National Travel Advice Line 




Malaria prevention in travellers can be complex and requires consideration of a 
number of factors. UK healthcare professionals providing pre-travel malaria advice 
can access specialist support from the National Travel Health Network and Centre 
(NaTHNaC) telephone advice line. 
The aim of this study is to characterise queries to the NaTHNaC telephone advice 
line regarding pre-travel malaria advice. 
Method: 
Telephone calls received to NaTHNaC’s advice line are recorded using an online 
data capture form. All calls relating to malaria advice during 2016 were selected and 
data extracted. Analysis was undertaken using Microsoft Excel and STATA.  
Results: 
During 2016, 1803 malaria-related calls were received; the majority from general 
practice and calls were from across the UK. The most common type of pre-travel 
malaria query was country-specific followed by travellers with special health needs. 
Many queries related to pregnant and breastfeeding travellers, children under 5 





This review presents a large and exceptional dataset and reflects the ambiguity 
amongst some healthcare professionals regarding malaria advice. We have 
identified potential knowledge gaps, and as a result will strengthen future guidance, 
enhance existing malaria maps, and inform the development of future clinical 
educational activity. 
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Introduction 
Malaria is a potentially life-threatening disease which is preventable and curable. 
Worldwide there were an estimated 219 million cases of malaria in 2017, from 90 
countries, compared to 239 million in 20101. Compared with 2016, 3 million more 
malaria cases were estimated to have occurred globally in 20172 . The WHO African 
region carries a disproportionately high percentage of the global malaria burden. In 
2017, the region accounted for 92% of malaria cases and 93% of malaria fatalities3.  
Between 2016 and 2017 an increased number of imported malaria cases were 
reported. In 2017, 1,792 cases of imported malaria were reported in the United 
Kingdom, 10.8% higher than reported in 2016 (N=1,618 cases). In the last 10 years 
(between 2008 and 2017), the total number of malaria cases reported in the UK each 
year has fluctuated around a mean of 1,558 (95% CI: 1,447-1,668); similar to the 
mean for the previous 10 years (1,533, 95% CI: 1,440-1,627)4. The majority of these 
cases were P.falciparum imported from Western Africa5 and there were 6 deaths 
reported in 20176.  In addition to the personal impact that malaria can have, there 
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can be a significant financial impact; for example, Rees and colleagues estimated 
the healthcare costs of malaria hospital admissions in London to be just over one 
million pounds per year7.  This is likely to be an underestimation of the true costs as 
they did not consider other healthcare and non-healthcare community costs or costs 
to the individual and family. 
Malaria prevention in travellers can be complex and requires consideration of a 
number of factors including the individual characteristics of the traveller, travel 
destination, duration of stay and type of travel.  It is further complicated by differing 
international guidelines8 and prescribing restrictions9. The Public Health England 
Advisory Committee on Malaria Prevention (ACMP) guidelines for malaria prevention 
in travellers from the UK and WHO guidance adhere with the ‘ABCD’ approach to 
malaria prevention. This covers awareness of risk of malaria, bite prevention, 
chemoprophylaxis, early diagnosis and treatment without delay10. 
UK healthcare professionals providing pre-travel malaria advice can access 
specialist support from the National Travel Health Network and Centre (NaTHNaC). 
NaTHNaC was set up by the Department of Health in 2002 with the broad aim of 
‘Protecting the Health of British Travellers’.  NaTHNaC seeks to improve the quality 
of travel health advice given by primary care providers, travel clinics, pharmacies 
and other healthcare providers, and provide up-to-date and reliable information for 
the traveller, travel industry and national government.  A key role of NaTHNaC is to 
provide guidance and education to health professionals. This is delivered through the 
website (www.travelhealthpro.org.uk), online courses and a travel health telephone 
advice line. The telephone advice line receives enquiries from all over the UK. This 
service is nurse-led with support from travel health physicians. The function of the 
telephone advice line is to provide support to healthcare professionals who are 
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assessing and managing travellers with complex itineraries or special health needs.  
The service received 6235 calls during 2016. An electronic data capture system to 
record details of telephone calls for auditing and research purposes was introduced 
in January 2016. 
The aim of this study was to characterise commonly raised queries to the NaTHNaC 
telephone advice line regarding pre-travel malaria advice.  This data can then be 
used to highlight areas where generic resources, provided on a national travel health 
website (Travel Health Pro), and national guidance could be strengthened. The 
information could also be used to develop country information pages, factsheets 
traveller advice algorithms (decision aids) and guide future educational activity. 
Methods 
Telephone calls received to NaTHNaC’s advice line are recorded and coded by a 
nurse-advisor using an online data capture form. Data on all calls received in 2016 
were extracted. All calls which were recorded as ‘malaria advice question’ were 
selected. In addition, calls with general enquiries regarding malaria and malaria-
related clinical incidents were included. 
Summary statistics were calculated for traveller age, gender, travel destinations, 
purpose of travel and reason for enquiry.  Further analysis, using STATA (version 
14.1, StataCorp) was undertaken for telephone calls which discussed; visiting friends 
and relatives (VFR) travellers, over-60 year olds, under-5 year olds, and travellers 
with special health needs. 
For calls concerning travellers with special health needs, all data including free text 
notes for medical conditions and medication of the first mentioned traveller per call 
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were extracted and coded to a medical condition using the International Statistical 
Classification of Diseases and Related Health Problems, 10th revision (ICD-10). For 
each traveller the total number of conditions and distinct ICD-10 categories were 
computed as measures of comorbidity. 
Structured and free text information about the destination of travel was coded to a 
WHO region.  
Results 
During 2016, 6235 calls were received of which 1803 (28.9%) were malaria-related. 
The majority of calls (83.3%) concerned only one traveller. These queries were 
received from a range of settings with GP practices accounting for 87.9% of all calls. 
Telephone calls were received from all parts of the UK with one fifth of calls (20.2%) 
being from the London region. The majority of travellers were travelling within 1 to 4 
weeks, and 8.7% were travelling within a week. The majority of trips were for 1 to 4 
weeks (55.7%).  Table 1 shows the different reasons for travel; tourism was the most 
common reason for travel followed by VFR travellers (26.8%). 
Table 1: Purpose of travel  
Purpose of travel N % 
Tourism 823 45.7 
VFR 483 26.8 
Backpacker 120 6.7 
Not known 94 5.2 
No data (not recorded) 73 4.1 
Business 52 2.9 
Other 36 2.0 
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Educational trip 35 1.9 
Volunteer 35 1.9 
Multiple categories 31 1.7 
Expatriate 11 0.6 
Relief aid worker 10 0.6 
Total  1803 100.0 
 
The gender of the traveller was documented in 88.1% of calls; of these calls 59.6% 
of queries concerned female travellers. The majority of travellers were aged between 
21 to 59 years. Travellers aged above 60 years accounted for 14.5%, children under 
the age of 5 years for 10.8%, and children less than one year old accounted for 6.9% 
of travellers. 
The most common type of pre-travel malaria query was country-specific followed by 
queries regarding travellers with special health needs.  Of the queries regarding 
country-specific advice; 61% were for single country destinations where 12.7% of 
these had a risk in the whole country and 0.9% had no malaria risk. Where there was 
variable risk within the country; 34% of countries had malaria recommendation maps 
available at the time of the query. Table 2 demonstrates the different categories of 
pre-travel malaria query which included long term travellers, travellers with a history 
of a medication-related adverse event profile, queries where multiple categories are 







Table 2: Malaria query type per call  
Malaria query type N % 
Country/itinerary specific 928 51.5 
Special health need 655 36.3 
No data 127 7.0 
Other 44 2.4 
Long term traveller 26 1.4 
Multiple categories mentioned 15 0.8 
Adverse event profile 8 0.4 
Total 1,803 100.0 
 
The most commonly mentioned destinations by WHO region were Africa (32%), 
Americas (22.5%), and South-East Asia (16%). Vietnam, Dominican Republic and 
Thailand were the most commonly discussed countries. Map 1 illustrates the top 20 
single countries mentioned in pre-travel malaria enquiries. The majority of VFR 











Map 1: The top 20 single countries mentioned in pre-travel malaria telephone enquiries. 
 
Map 2 illustrates the top 20 countries mentioned in pre-travel malaria enquiries when 
adjusting for UK traveller trips in 2015. This data has been taken from the 
International Passenger Survey which collects information about people entering and 
leaving the UK. Laos is the most frequently discussed country when adjusting for UK 







Map 2: Top 20 countries in 2016 adjusted by UK trips in 2015 (International Passenger Survey) 
 
Of all malaria-related calls, a total of 655 (36.3%) concerned travellers with special 
health needs. Of these queries, 255 calls concerned VFR travellers. The most 
common ICD-10 categories were ‘Pregnancy, childbirth and the puerperium’, 
‘Diseases of the circulatory system’ and ‘Mental and Behavioural Disorders’.  The 
most commonly mentioned medical conditions for this group included pregnancy, 
anxiety and/or depression and immunosuppression. Seventy-six travellers (11.6%) 
were considered immunosuppressed secondary to medication.  The ‘other’ category 
was varied with conditions not being listed if their frequency was less than 10 
travellers. Examples of conditions were haematological conditions including sickle 
cell disease, G6PD deficiency and haematological cancers, skin conditions including 
psoriasis and acne, tuberculosis, breast cancer and multiple sclerosis. The number 
of conditions per traveller ranged from 1 to 9 with 27.5% of travellers having co-
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morbidities. The majority of travellers with special health needs were female and 
aged between 21 to 59 years old; this was followed by men in the same age 
category. Travellers aged above 60 years old showed an equal split in gender.  
Table 3: Most commonly mentioned health conditions associated with malaria-related queries 
concerning travellers with special health need. 
Condition Freq. Percent 
Pregnancy 111 12.8 
Immunosuppression* 72 8.3 
Anxiety/depression 54 6.2 
Breastfeeding 45 5.2 
Epilepsy 41 4.7 
Hypertension 30 3.5 
HIV 21 2.4 
Rheumatoid arthritis 21 2.4 
Type 2 diabetes 19 2.2 
Pre-conception 16 1.8 
Systemic lupus erythematosus 13 1.5 
Thromboembolic disease 13 1.5 
Atrial fibrillation 12 1.4 
Renal transplant 12 1.4 
Asthma 11 1.3 
Type 1 diabetes 11 1.3 
Other 366 42.1 
Total 868 100.0 
*incl travellers prescribed immunosuppressive drugs without medical history coding (n = 27) 
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Of the travellers with special health needs, 308 travellers (47%) were reported to be 
on medication. The most common medication group were immunosuppressant 
medication (24.7%) followed by antidepressants or neuroleptic medication (12.3%).  
Table 4: Medication history of travellers with special health needs  
Drug group Percent 
Immunosuppressants 24.7 
Antidepressant or neuroleptic  12.3 
Anticoagulants 7.8 




* DMARDs: disease modifying anti-rheumatic drugs 
Pregnant women were the most common group of travellers with a special health 
need. Of these 111 women (66%) were VFR travellers and 19.8% had an additional 
special health need.  
Children under the age of 5 years accounted for 10.8% of calls; of these 63.9% of 
queries were related to children less than one year old. The majority of these 
children were VFR travellers. This contrasted to travellers over 60 years old as 
78.7% travelled for tourism. For this age group, 54% of calls related to a special 
health need; 48.4% were taking medication. Almost one third of this age group were 







This study demonstrates that pre-travel malaria advice queries to a national 
telephone advice line service cover a diverse range of travellers. Queries varied with 
regard to age of travellers, reason for travel, destination, and a large range of 
travellers with specific health needs. Pregnant and breastfeeding travellers, children 
aged under 5 years and travellers with immunosuppression were frequent.  
Many of the queries available could have been answered with currently available 
resources.  When healthcare professionals access the telephone line details for 
NaTHNaC they are directed to the TravelHealthPro website. This site has 
information on how to contact NaTHNaC but also provides signposting to country 
specific information and NaTHNaC factsheets. The country specific information 
pages will provide a malaria prevention advice  map of most countries; allowing 
health care professionals to assess if the traveller will be entering malaria zones.  
There are no maps available for countries where the advice is the same for the 
whole country.  At the time of this study 12 country maps were available (see 
appendix for a list of country maps). These maps are based on data from the Public 
Health England Advisory Committee of Malaria Prevention. 
The most commonly discussed WHO region was Africa and this is consistent with 
the global burden of malaria. The most commonly discussed countries were the 
Dominican Republic, Vietnam and Thailand accounting for 4.6%, 4.7% and 4.3 % of 
queries respectively. At the time of this review, UK malaria prevention advice was 
not uniform throughout the three countries which might explain the high number of 
calls combined with these countries being popular tourist destinations for UK 
travellers. However a malaria recommendation map was available for the Dominican 
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Republic which should have helped reduce any confusion regarding malaria risk 
areas.    
Vietnam and Thailand may also have been more commonly discussed due to 
mefloquine resistance being reported in both countries, and malaria prevention maps 
for these countries were not available at the time of the review.   
Since this review, maps are now available for Vietnam and Thailand, and 
chemoprophylaxis is no longer recommended for the Dominican Republic. It will be 
interesting to see if these changes will impact on the number of queries for these 
three countries in the future. The current Thailand malaria prevention advice map 
can be seen in Map 311.  
Map 3: 
 
The VFR traveller group represented a majority in the higher risk groups of pregnant 
and children under 1 year travellers; and two-thirds of travellers with a special health 
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need.  This group is also represented as a majority of imported malaria cases in the 
UK. During 2017, of those cases of imported malaria, 1221 cases travelled abroad 
from the UK and reason for travel was known for 84% of travellers. Of these, 80% 
were VFR travellers and the majority of this cohort were visiting friends and relatives 
in Africa12. This is consistent with our finding where the majority of VFR travellers 
were visiting Africa.  This data will allow us to ensure we provide targeted public 
health messaging to this higher risk group of travellers.  
Queries regarding pregnant women (12.8%), breastfeeding travellers (8.3%), 
children under 5 years (10.8%), and travellers over 60 years (14.5%) were common.   
NaTHNaC provide factsheets covering pregnant and breastfeeding travellers, older 
travellers and children. Detailed guidance for these groups is also available in the 
Public Health England ACMP guidelines.  The high call frequency for these groups 
could be due to a lack of clarity in the factsheets or guidelines, or the healthcare 
professional being unaware of such resources on the website. More likely it is due to 
a lack of confidence or need for reassurance particularly due to the higher risk of 
malaria, or of severe complications from malaria in these groups. In the case of 
pregnancy this is likely to be compounded by the limited data on medication safety 
and maternal and foetal outcomes13.   
Other commonly queried special health needs included immune suppression, mental 
health conditions (anxiety and depression) and epilepsy. Travellers with these 
conditions will be over represented for varying reasons. Advising travellers who are 
immune suppressed can be complex due to their increased risk of serious travel-
related infection, furthermore, their underlying condition or medications can 
contraindicate, or increase the toxicity of malaria chemoprophylaxis. For travellers 
with mental health conditions restrictions in prescribing mefloquine and interactions 
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with other malaria chemoprophylaxis may be a challenge. Similarly for individuals 
with epilepsy, the contra-indication of certain chemoprophylactic drugs and the 
potential for drug interactions can be difficult. 
For these complex traveller groups, guidelines cannot cover every scenario, and this 
may be reflected in the higher call frequency. Even if guidance is available, the more 
frequent calls for complex groups of travellers could reflect a lack of confidence 
amongst some healthcare professionals and the preference to telephone for advice, 
which enables a discussion and reassurance for the healthcare professional, rather 
than using guidelines.  Advising these groups of travellers therefore requires the 
healthcare professional to be confident and comfortable with their decisions 
particularly if these scenarios are not commonly encountered, and this may explain 
why we observed a high frequency of calls.  
Female travellers with a special health need were more common in the 21 to 59 
years age group, but this is likely to be due to the fact that within this age group 25% 
of women were pregnant or breastfeeding (p<0.0001). 
Overall, the characteristics of travellers most frequently queried are consistent with 
other studies14. In 2012, a French study which summarised the characteristics of 
international travellers at a pre-travel clinic in Marseille demonstrated 10% of this 
group were older travellers (greater than 60 years old) and the prevalence of chronic 
medical conditions in this group was 27%15. They found age, last-minute travel, 
neurological (migraine followed by epilepsy was the most common disease) and 
psychiatric conditions were the most common factors to influence malaria 
chemoprophylaxis. Another similar study published by Global TravEpinet 
demonstrated 59% of travellers had one or more medical condition16. In 2013, the 
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Public Health England Malaria Reference Laboratory published a retrospective 
observational study of enquiries to their specialist advisory service for queries from 
healthcare professionals17. This study also reflected the difficulty in balancing 
comprehensive guidelines whilst ensuring they are still ‘user-friendly’ and accessible. 
They concluded pregnant travellers and travellers with epilepsy were areas where 
guidance needed to be strengthened. Bar the Malaria Reference Laboratory and 
NaTHNaC, to our knowledge, there are no other published comparable data.  
The limitations of this study are its retrospective nature and the dependence on a 
nurse-advisor entering data and coding call records; not all call records have 
completed clinical information. This is an observational study and due to the 
specialist nature of the service, the findings do not necessarily reflect the concerns of 
practitioners who seek no advice or travellers who do not seek pre-travel advice. 
However, strengths of this study include the large dataset and national coverage. 
Telephone calls were documented for research purposes therefore allowing for 
greater consistency in data collection. 
Conclusion 
This review presents a large and exceptional dataset and reflects the ambiguity 
amongst some healthcare professionals regarding malaria advice. Travellers in this 
review were a very diverse group representing a wide age range, with a varied range 
of underlying medical conditions and travel destinations. 
The types and frequency of enquiries to the advice line are likely to reflect a lack of 
confidence or need for reassurance in healthcare professionals advising specific 
groups of travellers about malaria.  They may also reflect difficulty in interpreting 
current guidelines particularly in relation to country specific recommendations where 
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the malaria risk is not considered to be uniform throughout the country.   There is 
also a possibility that there is a lack of awareness of the existence of the available 
resources, but this seems unlikely by virtue of the fact that the callers had contacted 
a specialist national travel health advice line for advice.  
This research has highlighted some of the concerns of front-line healthcare 
professionals when advising travellers about malaria. The callers likely represent a 
range of experience, and the primary motivation of the healthcare professional for 
calling would be an interesting area to research in the future. 
This study has also identified potential knowledge gaps, and the findings will help 
strengthen future guidance, develop existing malaria maps, and to inform the 
development of future healthcare professional educational activities. In late 2017, 
there were major changes to the ACMP guidelines and in late 2018/early 2019 
NaTHNaC launched eight interactive malaria maps for Bangladesh, Bolivia, Brazil, 
Ethiopia, India, Kenya, Pakistan and Tanzania. These searchable malaria 
recommendation maps have been loaded on the matching Country Information 
Pages, making it possible to search for individual destinations on each country map 
and see the malaria recommendations for that region. These changes may result in 
greater clarity for healthcare professionals particularly for those who have country 
specific queries for pre-travel malaria advice. It will be interesting to evaluate malaria 
queries in the future to evaluate the impact of these changes. 
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